News search

    E.g., 15/09/2025
    E.g., 15/09/2025
    ESC Congress 2025
    About the CNIC
    30 Aug 2025
    EHJ: New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

    The REBOOT study was presented during the European Society of Cardiology Congress (ESC Congress 2025) in Madrid
    Figure
    Research
    13 Sep 2024
    The RESILIENCE trial: preventing heart injury caused by anticancer drugs

    RESILIENCE is a clinical trial funded by the European Commission (H2020 Programme) that aims to reduce the prevalence of heart failure in cancer survivors
    About the CNIC
    6 Aug 2021
    RREBOOT, on a mission to change clinical practice guidelines for the treatment of heart attack survivors

    CNIC and the Mario Negri Institute in Milan (Italy) coordinate REBOOT, a project that aims to study whether treatment with beta-blockers is beneficial for patients who have suffered a myocardial infarction

    Borja Ibáñez
    About the CNIC
    10 Jun 2021
    Dr Borja Ibáñez wins the Fundación Jesús Serra Research Award for his work in the fields of nutrition and food science

    The €35,000 awarded by the foundation in each category is for research that deepens knowledge of the relationship between nutrition, food and health
    Research
    9 Oct 2020
    EHJ: Metoprolol: an old drug with unique cardioprotective properties

    CNIC scientists have defined the unique ability if metoprolol to protect the heart during a heart attack
    Borja Ibáñez, Carlos Galán, Rodrigo Fernández, Eduardo Oliver, Gonzalo Pizarro, Manuel Lobo, Jean Paul Vilchez Tschischke, Antonio de Molina-Iracheta, Rocío Villena y Javier Sánchez-González
    Research
    19 Feb 2019
    JACC: Identified a very early marker of cardiac damage triggered by cancer treatment

    The results have implications for patient prognosis, since detection of this marker can prompt intervention to prevent irreversible damage
    About the CNIC
    30 Nov 2018
    A Project by Borja Ibáñez from the CNIC and the FJD funded by the European Union with an ‘ERC Consolidator’
    About the CNIC
    1 Jun 2017
    Dr. Borja Ibáñez awarded the XII Banco Sabadell Foundation Award for Biomedical Research

    Dr. Ibáñez, Director of Clinical Research at the CNIC, has received an award for his contribution to the fight against cardiovascular diseases
    Research
    1 Jul 2010
    Borja Ibáñez recibe el premio IMPULSA de la Fundación Príncipe de Girona que reconoce el talento de jóvenes emprendedores

    El Premio Impulsa Ciencia y Academia se concede a una persona que haya desarrollado su actividad en el marco de un proyecto de investigación o docencia  que despunte en su disciplina